Imatinib Withdrawn Phase 1 / 2 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs